Bitter Pills:Medicines & The Third World Poor | Page 37

Name

Hoechst
Bayer
Hoffmann La Roche
Merck
Ciba-Geigy
American Home Products
Sandoz
Pfizer
Lilly
Takeda
Boehringer-Ingelheim
Warner-Lambert
Rhone-Poulenc
Upjohn
Bristol-Myers
Squibb
Schering-Plough
Abbott
Smith Kline
Glaxo
Sterling-Winthrop
Schering AG
Beecham
Johnson and Johnson
ICI

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

2 300
1 850

2 200
890
380
355
355
279
242
193
063
062
027
971
907
859
745
723
690
683
671
670
661
640
635
608
599
2 004
1 595
1 448
1 289
1 430
1003
1092
1 092
1 045
1 242
956
946
900
757
830
862
955
768
635
711
760
697

$M
1979

$M
1978

6

53
49
64
68
58
42
31

As % Total
Sales in
1979
16
13
44
84
28
43
48
52
45
59
77
32
16
63
34
As % World
Total
1978
3.8
3.2
2.4
2.4
2.4
2.2
2.2
2.1
1.9
1.9
1.8
1.7
1.6
1.5
1.3
1.3
1.2
1.2
1.2
1.2
1.2
1.1
1.1
1.1
1.1
9
9
12
6
13
8
15
7
11
8
8
13
11
7
9
8
10
8
7
14
11
10
9

300
180
190
90
170
120
150
80
120
80
100
120
100
60
70
70
90
75
50
90
70
80
65

As % Drug
Sales

200

$M

1979 R&D
Expenditure

German
German
Swiss
American
Swiss
American
Swiss
American
American
Japanese
German
American
French
American
American
American
American
American
American
British
American
German
British
American
British

Origin

Figures from company reports and from information from Interpharma; Scrip, various issues; Aries, op.cit.; European Chemical News, various issues. R&D expenditures are
approximate and should be used with caution. They have however been considered as realistic estimates by industrial experts consulted.
Table A.2., page 243 of the English original study.

Rank

Pharmaceutical Sales

THE MAJOR PHARMACEUTICAL COMPANIES OF THE WORLD, 1978-1979

1" /O

1Q78

Diagram 4.